Climb Bio Inc.

NASDAQ: CLYM · Real-Time Price · USD
1.93
0.21 (12.21%)
At close: Aug 15, 2025, 3:59 PM
1.92
-0.55%
After-hours: Aug 15, 2025, 07:44 PM EDT

Climb Bio Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
38K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
-38K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-56.34M -102.03M -82.02M -76.23M -69.5M -19.84M -40.27M -44.71M -48.45M -55.44M -45.13M -46.28M -46.92M -41.92M -35.67M -40.08M -32.95M -25.85M
Interest Income
4.81M 4.81M 3.86M 2.69M 3.95M 3.95M 3.51M 2.16M 1.28M 1.28M 383K 383K n/a n/a n/a n/a n/a n/a
Pretax Income
-46.76M -92.98M -73.9M -69.12M -64.19M -14.53M -35.12M -39.24M -44.95M -54.33M -45.24M -48.03M -47.96M -42.08M -47.48M -51.8M -44.44M -37.35M
Net Income
-46.76M -92.98M -73.9M -69.12M -64.19M -14.53M -35.12M -39.24M -44.95M -54.33M -45.24M -48.03M -47.96M -42.08M -47.48M -51.8M -44.44M -37.35M
Selling & General & Admin
20.2M 19.8M 16.02M 13.07M 9.7M 9.06M 24.86M 27.5M 29.86M 31.77M 18.92M 18.12M 17.02M 15M 12.35M 10.06M 6.98M 4.32M
Research & Development
36.1M 82.23M 66M 63.16M 59.8M 10.78M 15.41M 17.21M 18.59M 23.67M 26.21M 28.17M 29.9M 26.92M 23.32M 20.86M 16.81M 12.38M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 9.16M 9.16M 9.16M
Operating Expenses
56.3M 102.03M 82.02M 76.23M 69.5M 19.84M 40.27M 44.71M 48.45M 55.44M 45.13M 46.28M 46.92M 41.92M 35.67M 40.08M 32.95M 25.85M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
56.34M 102.03M 82.02M 76.23M 69.5M 19.84M 40.27M 44.71M 48.45M 55.44M 45.13M 46.28M 46.92M 41.92M 35.67M 40.08M 32.95M 25.85M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
67.59M 67.46M 64.74M 67.01M 30.35M 27.64M 27.31M 27.07M 26.84M 26.54M 26.37M 26.34M 26.3M 26.24M 26.23M 15.59M 23.46M 11.66M
Shares Outstanding (Diluted)
67.59M 67.46M 64.74M 67.01M 30.35M 27.64M 27.31M 27.07M 26.84M 26.54M 26.37M 26.34M 26.3M 26.24M 26.23M 15.59M 23.46M 11.66M
EPS (Basic)
-0.7 -2.38 -2.13 -2.13 -2.15 -0.53 -1.31 -1.47 -1.69 -2.06 -1.72 -1.83 -2.16 -2.06 -3.25 -4.12 -3.65 -3.37
EPS (Diluted)
-0.7 -2.38 -2.13 -2.13 -2.15 -0.53 -1.31 -1.47 -1.69 -2.06 -1.72 -1.83 -2.16 -2.06 -3.25 -4.12 -3.65 -3.37
EBITDA
-54.29M -102.03M -82.02M -76.23M -69.5M -19.84M -40.27M -44.71M -48.45M -55.44M -45.13M -46.28M -46.92M -41.92M -35.67M -30.92M -23.79M -16.7M
EBIT
-54.33M -102.03M -82.02M -76.23M -69.5M -19.84M -40.27M -44.71M -48.45M -55.44M -45.13M -46.28M -46.92M -41.92M -35.67M -30.92M -23.79M -16.7M
Depreciation & Amortization
38K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a